The much anticipated results of a phase 2 clinical trial of exenatide have been published in The Lancet, and have since appeared widely in the media. The findings offer hope that drugs like exenatide can slow the course of Parkinson’s — something no current treatment can do. So, generally how does exenatide work?
What is Glucagon-like peptide 1?
Glucagon-like peptide 1 is a hormone produced in the gut and released in response to food. It causes reduced appetite and the release of insulin.